派博傳思國際中心

標題: Titlebook: HMG-CoA Reductase Inhibitors; Gerd Schmitz,Michael Torzewski Book 2002 Springer Basel AG 2002 atherosclerosis.cardiovascular.coronary arte [打印本頁]

作者: 指責    時間: 2025-3-21 16:23
書目名稱HMG-CoA Reductase Inhibitors影響因子(影響力)




書目名稱HMG-CoA Reductase Inhibitors影響因子(影響力)學科排名




書目名稱HMG-CoA Reductase Inhibitors網(wǎng)絡公開度




書目名稱HMG-CoA Reductase Inhibitors網(wǎng)絡公開度學科排名




書目名稱HMG-CoA Reductase Inhibitors被引頻次




書目名稱HMG-CoA Reductase Inhibitors被引頻次學科排名




書目名稱HMG-CoA Reductase Inhibitors年度引用




書目名稱HMG-CoA Reductase Inhibitors年度引用學科排名




書目名稱HMG-CoA Reductase Inhibitors讀者反饋




書目名稱HMG-CoA Reductase Inhibitors讀者反饋學科排名





作者: fallible    時間: 2025-3-21 23:57

作者: 好開玩笑    時間: 2025-3-22 03:28

作者: MIME    時間: 2025-3-22 06:06

作者: anus928    時間: 2025-3-22 11:10

作者: 空氣    時間: 2025-3-22 13:58
The Hatfield Photographic Lunar Atlasarction or stroke is of particular relevance, because, in addition to the considerable impairment to health, it creates immense economic demands. Atherosclerosis plays a central role as an etiological component in the development of this disease. The scientific data published in the past decade are
作者: HACK    時間: 2025-3-22 20:30

作者: PAN    時間: 2025-3-22 21:16
https://doi.org/10.1007/978-1-4614-8639-8e substantial. Consequently, both the primary and secondary prevention of CHD are major objectives of healthcare systems worldwide. Recently, large, multi-centre, clinical trials have demonstrated consistently that these objectives can be achieved though cholesterol-lowering therapy with 3-hydroxy-3
作者: 交響樂    時間: 2025-3-23 01:53

作者: 衍生    時間: 2025-3-23 07:57
Structure and mechanisms of action of HMG-CoA reductase inhibitors,ich remains the leading cause of death in our society [.]. The efficacy of LDL reduction in the prevention of CHD has clearly been demonstrated in a number of primary and secondary intervention trials (reviewed in reference [.]). Inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductas
作者: 是他笨    時間: 2025-3-23 12:24
Sterol-regulatory element binding proteins (SREBPs): gene-regulatory target of statin action,of clinical overt cardiovascular complications, like myocardial infarction or stroke, but has almost no effect on angiographically determined luminal diameter of coronary arteries. These, as well as many morphological and molecular studies, have led to a new paradigm of coronary heart disease, i.e.,
作者: AVERT    時間: 2025-3-23 15:32
Cellular effects of HMG-CoA reductase inhibitors on blood cells (monocytes, macrophages, platelets)zed societies. Several important environmental and genetic risk factors are associated with atherosclerosis. Over the past decade, it has become evident that atherosclerosis is not simply an inevitable degenerative consequence of ageing, but rather a chronic inflammatory condition connecting altered
作者: Amnesty    時間: 2025-3-23 19:59
Pleiotropic effects of HMG-CoA reductase inhibitors on cells of the vascular wall,ts, cholesterol becomes an important risk factor for cardiovascular disease, as demonstrated in clinical trials from the Framingham Heart Study [.–.] and the Multiple Risk Factor Intervention Trial [., .]. Although dietary cholesterol can contribute to changes in serum cholesterol levels, more than
作者: 窩轉(zhuǎn)脊椎動物    時間: 2025-3-23 23:20

作者: FLAT    時間: 2025-3-24 06:02

作者: Meditate    時間: 2025-3-24 09:56
Cost-effectiveness of statins in primary and secondary prevention of coronary heart disease,e substantial. Consequently, both the primary and secondary prevention of CHD are major objectives of healthcare systems worldwide. Recently, large, multi-centre, clinical trials have demonstrated consistently that these objectives can be achieved though cholesterol-lowering therapy with 3-hydroxy-3
作者: 廣大    時間: 2025-3-24 12:00

作者: handle    時間: 2025-3-24 15:37
Milestones in Drug Therapyhttp://image.papertrans.cn/h/image/420250.jpg
作者: acclimate    時間: 2025-3-24 21:45

作者: Neutral-Spine    時間: 2025-3-25 00:29

作者: 有危險    時間: 2025-3-25 05:03

作者: Regurgitation    時間: 2025-3-25 08:41

作者: 事情    時間: 2025-3-25 11:44
Michael D. Robinson,Michael Eid hypercholesterolemia [.]. Clinical trials have demonstrated that they can induce regression of vascular atherosclerosis, as well as reduction of cardiovascular-related morbidity and mortality, in patients with and without coronary artery disease CAD [.–.]. These trials provide a powerful endorsemen
作者: 抑制    時間: 2025-3-25 17:22
Swarup Bhunia,Mark M.‘Tehranipoortible to rupture or fissuring, thereby being a focus of high risk for thrombus formation. Rupture with consecutive thrombus formation can cause an acute coronary syndrome, such as unstable angina or myocardial infarction. So far reduction of plasma cholesterol by lipid-lowering therapy has been show
作者: 中世紀    時間: 2025-3-25 22:26

作者: Angioplasty    時間: 2025-3-26 00:57

作者: 權(quán)宜之計    時間: 2025-3-26 04:37

作者: MORT    時間: 2025-3-26 08:42
Sterol-regulatory element binding proteins (SREBPs): gene-regulatory target of statin action,tible to rupture or fissuring, thereby being a focus of high risk for thrombus formation. Rupture with consecutive thrombus formation can cause an acute coronary syndrome, such as unstable angina or myocardial infarction. So far reduction of plasma cholesterol by lipid-lowering therapy has been show
作者: Thyroiditis    時間: 2025-3-26 13:37

作者: Granular    時間: 2025-3-26 18:28
Cost-effectiveness of statins in primary and secondary prevention of coronary heart disease,as the elderly, will also be considered. In addition, we will also consider the relative cost-effectiveness of different statin therapies. Finally, we will consider the cost-effectiveness of statin therapy and resource utilisation in relation to healthcare provision.
作者: concentrate    時間: 2025-3-26 21:48

作者: 他很靈活    時間: 2025-3-27 01:36

作者: Flinch    時間: 2025-3-27 05:46
https://doi.org/10.1007/1-84628-236-5ality [.–.]. In addition, similar results were obtained with a couple of large-scale drug interventions with cholestyramine [.] and nicotinic acid [.]. On the basis of these studies, it could be anticipated that atherosclerosis is a reversible disease.
作者: Nostalgia    時間: 2025-3-27 11:46
Clinical experience: studies with HMG-CoA reductase inhibitors,ality [.–.]. In addition, similar results were obtained with a couple of large-scale drug interventions with cholestyramine [.] and nicotinic acid [.]. On the basis of these studies, it could be anticipated that atherosclerosis is a reversible disease.
作者: 多產(chǎn)魚    時間: 2025-3-27 16:20
2296-6056 thermore, they induce regression of vascular atherosclerosis as well as reduction of cardiovascular-related morbidity and death in patients with and without coronary artery disease. This book deals with statins which have substantially altered the approach to therapy of atherosclerosis and its seque
作者: ILEUM    時間: 2025-3-27 21:01
https://doi.org/10.1007/978-981-15-7549-5nt that atherosclerosis is not simply an inevitable degenerative consequence of ageing, but rather a chronic inflammatory condition connecting altered cholesterol metabolism and other risk factors to the development and progression of the atherosclerotic lesion and its sequelae like plaque rupture, fibrosis, calcification and thrombosis [.].
作者: JIBE    時間: 2025-3-27 22:52
Cellular effects of HMG-CoA reductase inhibitors on blood cells (monocytes, macrophages, platelets)nt that atherosclerosis is not simply an inevitable degenerative consequence of ageing, but rather a chronic inflammatory condition connecting altered cholesterol metabolism and other risk factors to the development and progression of the atherosclerotic lesion and its sequelae like plaque rupture, fibrosis, calcification and thrombosis [.].
作者: CRASS    時間: 2025-3-28 04:50

作者: ALT    時間: 2025-3-28 08:49

作者: Frenetic    時間: 2025-3-28 13:11





歡迎光臨 派博傳思國際中心 (http://www.pjsxioz.cn/) Powered by Discuz! X3.5
南京市| 宁晋县| 伊宁县| 广昌县| 方山县| 京山县| 武平县| 木兰县| 北宁市| 吉林省| 仪征市| 德安县| 大宁县| 海门市| 伊川县| 望都县| 福海县| 大同县| 天台县| 乾安县| 红安县| 黄骅市| 柳州市| 丹巴县| 武乡县| 泰安市| 赤水市| 商丘市| 临城县| 樟树市| 保定市| 西林县| 揭西县| 密山市| 庆城县| 涞水县| 视频| 江源县| 永清县| 鹰潭市| 克拉玛依市|